← All diseases Liver, kidneys and digestion

Primary biliary cholangitis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest evidence only (95)Meta-analysis (34)Treatment guideline (10)Randomized trial (22)Phase 3 Study (15)Systematic review (14)Clinical examination (354)Review article (274)Early study (phase 1 or 2) (18)Case reports (145)Laboratory or animal study (50)Commentary or editorial (39)Retracted publication (2) Studies currently recruiting participants only (32)

Filter

Publications and studies (1841)

• Clinical Outcomes of Transcatheter Arterial Embolization Using N-Butyl-2-Cyanoacrylate (NBCA) in Cirrhotic Patients. (2022/03/01) ♡
• Progressive Familial Intrahepatic Cholestasis: A Study in Children From a Liver Transplant Center in India. (2022/03/01) ♡
• Giant Cell Hepatitis in Copper Toxicosis. (2022/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Hepatic Regeneration in Cirrhosis. (2022/03/01) ♡
• Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies. (2022/03/01) ♡
• Comparative Evaluation of Anti-Fibrotic Effect of Tissue Specific Mesenchymal Stem Cells Derived Extracellular Vesicles for the Amelioration of CCl4 Induced Chronic Liver Injury. (2022/03/01) ♡
• Associations Between Autoimmune Conditions and Gastric Cancer Risk Among Elderly Adults in the United States. (2022/03/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Posttransplant immune-mediated cholangiopathies. (2022/03/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Progressive Familial Intrahepatic Cholestasis: Need for Genetic Analysis Before Liver Transplantation. (2022/03/01) ♡
• Saroglitazar for Nonalcoholic Fatty Liver Disease: A Single Center Experience in 91 Patients. (2022/03/01) ♡
• Protein and miRNA profile of circulating extracellular vesicles in patients with primary sclerosing cholangitis. (2022/02/22) ♡
• Vitamin D Is Associated with Clinical Outcomes in Patients with Primary Biliary Cholangitis. (2022/02/19) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Autophagy and Exosomes: Cross-Regulated Pathways Playing Major Roles in Hepatic Stellate Cells Activation and Liver Fibrosis. (2022/02/03) ♡
• Diagnosis of liver cirrhosis with two-dimensional shear wave elastography in biliary atresia before Kasai portoenterostomy. (2022/02/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. The need for early Kasai portoenterostomy: a Western Pediatric Surgery Research Consortium study. (2022/02/01) ♡
• Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis. (2022/02/01) ♡
• Corrigendum to 'An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs' [J Hepatol 2021;75(3):572-581]. (2022/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Acquired palmoplantar keratoderma associated with primary biliary cholangitis: Complete and persistent resolution after ursodeoxycholic acid treatment. (2022/02/01) ♡
• The diagnostic value of contrast-enhanced ultrasound LI-RADS for hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis B. (2022/02/01) ♡
• Feasibility of liver stiffness measured using two-dimensional shear wave elastography in assessing preoperative liver function for patients with hepatocellular carcinoma. (2022/02/01) ♡
• Increased sensitivity of gp210 autoantibody detection using a newly designed gp210 antigen. (2022/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Long-term outcomes of biliary atresia patients surviving with their native livers. (2022/02/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cystic fibrosis-related liver disease: Clinical presentations, diagnostic and monitoring approaches in the era of CFTR modulator therapies. (2022/02/01) ♡
• Immune-Mediated Diseases Associated With Cancer Risks. (2022/02/01) ♡
• Mitigation of portal fibrosis and cholestatic liver disease in ANKS6-deficient livers by macrophage depletion. (2022/02/01) ♡
• Liver stiffness can predict decompensation and need for beta-blockers in compensated cirrhosis: a step beyond Baveno-VI criteria. (2022/02/01) ♡
• Randomized researchiParticipants were divided into groups by lottery and compared with each other. This reduces the chance that a difference is due to something other than the treatment. Effect of long-term aggressive nutrition therapy on survival in patients with alcohol-related cirrhosis: A randomized controlled trial. (2022/02/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Kasai Operation in Biliary Atresia After Extensive Bowel Resection. (2022/01/24) ♡
• Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study. (2022/01/20) ♡
• Gender-specific development of experimental autoimmune cholangitis induced by double-stranded RNA. (2022/01/15) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. ADAM Metalloproteinase Domain 17 regulates Cholestasis-Associated Liver Injury and Sickness Behavior Development in Mice. (2022/01/13) ♡
• QTc interval prolongation in the patients with primary biliary cholangitis. (2022/01/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. rs9459874 and rs1012656 in CCR6/FGFR1OP confer susceptibility to primary biliary cholangitis. (2022/01/01) ♡
• Indication for Liver Transplantation After Direct-Acting Agents in the Treatment of Patients With Hepatitis C. (2022/01/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Refractory Acute Antibody Mediated Rejection in Liver Transplant After Desensitization of Preformed Donor Specific Antibody-Validity of Bortezomib and Everolimus: A Case Report. (2022/01/01) ♡
• The hypotaurine-taurine pathway was an antioxidant mechanism in patients with acute liver failure. (2022/01/01) ♡
• Diagnosis of Primary Sclerosing Cholangitis Beyond Childhood is Associated with Worse Outcomes. (2022/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Meta-analysis and systematic review of liver transplantation as an ultimate treatment option for secondary sclerosing cholangitis. (2022/01/01) ♡
• Diffuse increased uptake in intrahepatic biliary ducts on (18) F-FDG PET/CT in a case with primary sclerosing cholangitis. (2022/01/01) ♡
• Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. Non-invasive diagnosis and follow-up of autoimmune hepatitis. (2022/01/01) ♡
• May Previous Hepatitis B Virus Infection Be Involved in Etiology and Pathogenesis of Autoimmune Liver Diseases? (2022/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Liver specific, systemic and genetic contributors to alcohol-related liver disease progression. (2022/01/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. A Current Understanding of Bile Acids in Chronic Liver Disease. (2022/01/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0159 (2022-10-18) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Vidofludimus Calcium for Primary Sclerosing Cholangitis (2022-10-17) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC) (2022-10-17) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid (2022-09-30) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of Obeticholic Acid (OCA) Evaluating Pharmacokinetics and Safety in Participants With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (2022-09-06) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis (2022-08-24) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. sCD163 in PBC Patients - Assessment of Disease Severity and Prognosis (2022-08-12) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.